We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Presses Urokinase Drugmakers to Estimate Pathogen Contamination Risk
Guidance Presses Urokinase Drugmakers to Estimate Pathogen Contamination Risk
The European Medicines Agency is urging manufacturers of urokinase-based drugs to estimate the chances that an individual dose of a product might be contaminated with pathogens.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor